Japer Therapeutics Inc. Warrants (JSPRW) Live Share Price, Invest From India

Japer Therapeutics Inc. Warrants Stock Performance

as on July 3, 2026 at 2:15 pm IST

$0.01
Day's Price Range
$0.01
$0.01
52 Week's Low
52 Week's High
52-Week Price Range
$0.01
100.00%
Downside
-100.00%
Upside

Japer Therapeutics Inc. Warrants share price movements today

Previous Close: $0.01
Open: $0.01
Volume: 185.0
Day's Low - High: $0.01 - $0.01

Japer Therapeutics Inc. Warrants Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Japer Therapeutics Inc. Warrants Stock Fundamentals & Key Indicators

Check Japer Therapeutics Inc. Warrants market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-244.21%

Japer Therapeutics Inc. Warrants stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Japer Therapeutics Inc. Warrants with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Japer Therapeutics Inc. Warrants	NA	$-	NA	NA	0.00%	NA

Japer Therapeutics Inc. Warrants Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	2	-	-	-	1	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	-	0	0
Operating Income	-17	-15	-15	-19	-25	-21	-27	-19	-15	-10
EBITDA	-16	-13	-14	-18	-24	-20	-26	-18	-8	-1
Interest Expense	0	-	-	-	5	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-16	-13	-14	-18	-24	-21	-26	-18	-9	-1
Income Tax Expense	1	0	0	-	0	-	-	-	-	-
Net Income	-16	-13	-14	-18	-24	-21	-26	-18	-9	-1
Net Profit Margin	-808.04%	0.00%	0.00%	0.00%	-2071.64%	0.00%	0.00%	0.00%	0.00%	0.00%

Japer Therapeutics Inc. Warrants Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	-1	-1	-1	-1
Operating Income	-20	-36	-51	-68	-76	-80
EBITDA	-31	-30	-36	-63	-69	-74
Interest Expense	-	6	13	-	-	-
Depreciation	-	0	0	1	1	1
Income Before Tax	-31	-30	-37	-64	-71	-75
Income Tax Expense	0	-1	-13	-1	-1	-
Net Income	-31	-30	-37	-64	-71	-75
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Japer Therapeutics Inc. Warrants Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-13	-14	-18	-24	-21	-26	-18	-9	-1
Operating Cash Flow	-15	-11	-14	-21	-22	-15	-16	-21	-14
Investing Cash Flow	0	0	0	0	0	0	0	0	-
Financing Cash Flow	47	0	0	0	-	6	28	0	-
Change in Cash	31	-11	-14	-20	-22	-9	11	-22	-14

Japer Therapeutics Inc. Warrants Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-31	-30	-37	-64	-71	-75
Operating Cash Flow	-18	-33	-45	-52	-62	-77
Investing Cash Flow	0	-2	0	0	0	0
Financing Cash Flow	11	100	0	100	47	34
Change in Cash	-6	64	-46	48	-15	-42

About Japer Therapeutics Inc. Warrants

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma. Jasper Therapeutics, Inc. was founded in 2018 and is headquartered in Redwood City, California.

Organisation	Japer Therapeutics Inc. Warrants
Headquarters	2200 Bridge Pkwy, Redwood City, CA, United States, 94065
Industry	Health Care
CEO	Mr. Thomas G. Wiggans
E-voting on shares	Click here to vote

Key Management of Japer Therapeutics Inc. Warrants

Name	Title
Mr. Thomas G. Wiggans	Executive Chairman
Alex Gray	Head of Investor Relations
Mr. Matthew Ford	Senior Vice President of Human Resources
Dr. Luca Di Noto Ph.D.	Senior Vice President of Technical Operations

FAQs

What is Japer Therapeutics Inc. Warrants share price today?

Japer Therapeutics Inc. Warrants share price today is $0.01 as on July 3, 2026 at 8:45 am IST at the close of the market. Japer Therapeutics Inc. Warrants share today touched a day high of $0.01 and a low of $0.01.

What is the 52 week high and 52 week low for Japer Therapeutics Inc. Warrants share?

Japer Therapeutics Inc. Warrants share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Japer Therapeutics Inc. Warrants stock price today i.e. July 3, 2026 at 8:45 am IST is closed at $0.01,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in Japer Therapeutics Inc. Warrants Stock (JSPRW) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Japer Therapeutics Inc. Warrants on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Japer Therapeutics Inc. Warrants Shares that will get you 150.0000 shares as per Japer Therapeutics Inc. Warrants share price of $0.01 per share as on July 3, 2026 at 8:45 am IST.

What is the minimum amount required to buy Japer Therapeutics Inc. Warrants Stock (JSPRW) from India?

Indian investors can start investing in Japer Therapeutics Inc. Warrants (JSPRW) shares with as little as ₹95.2 or $1 (as of July 5, 2026 at 6:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Japer Therapeutics Inc. Warrants stock (as per the Rupee-Dollar exchange rate as on July 5, 2026 at 6:37 am IST). Based on Japer Therapeutics Inc. Warrants share’s latest price of $0.01 as on July 3, 2026 at 8:45 am IST, you will get 1000.0000 shares of Japer Therapeutics Inc. Warrants. Learn more about fractional shares .